Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $101

Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $101

Morgan Stanley analyst Joseph Moore maintains Teradyne (NASDAQ:TER) with a Equal-Weight and raises the price target from $92 to $101.

byBenzinga Newsdesk

January 27, 2023

1 minute read

Morgan Stanley analyst Joseph Moore maintains Teradyne (NASDAQ:TER) with a Equal-Weight and raises the price target from $92 to $101.

P/E Ratio Insights for Broadcom

By Benzinga Insights

June 26, 4:02 PM

In the current session, the stock is trading at $825.59, after a 0.42% increase. Over the past month,…

AVGO

Reed’s Lowers FY22 Revenue Outlook To $56M – $59M From $59M – $62M Prior, Vs. $60.35M Estimate

By Benzinga Newsdesk

November 10, 5:19 PM

FY 2022 Financial Guidance and Outlook Reed's expects 2022 net sales to range between approximately $56-59 million, reflecting growth of approximately 13-19% from 2021. The Company also expects gross margin in 2022

REED

Latest PC, Chips And Memory Data Worries Analyst, Who Jumps Ship On Two Stocks

By Anusuya Lahiri

September 21, 3:16 PM

Mizuho analyst Vijay Rakesh downgraded Micron Technology, Inc (NASDAQ: MU) to Neutral from

Wedbush Initiates Coverage On Keurig Dr Pepper with Outperform Rating, Announces Price Target of $43

By Benzinga Newsdesk

October 11, 5:24 AM

Wedbush analyst Gerald Pascarelli initiates coverage on Keurig Dr Pepper (NASDAQ:KDP) with a Outperform rating and announces Price Target of $43.

KDP

Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $101

Related Posts

P/E Ratio Insights for Broadcom

Reed’s Lowers FY22 Revenue Outlook To $56M – $59M From $59M – $62M Prior, Vs. $60.35M Estimate

Latest PC, Chips And Memory Data Worries Analyst, Who Jumps Ship On Two Stocks

Wedbush Initiates Coverage On Keurig Dr Pepper with Outperform Rating, Announces Price Target of $43